Correction to: Leukemia https://doi.org/10.1038/s41375-024-02253-3, published online 18 April 2024
In the version of the article initially published, important funding information was missing. ‘This study was partially funded by EU FP7-HEALTH - Specific Programme “Cooperation”: Health (Grant agreement ID: 602602). UM was supported by National Cancer Institute 2R01CA176647 and by a Carol Baldwin Foundation TRO’ has been added.
The original article has been corrected.”
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Arends, C.M., Kopp, K., Hablesreiter, R. et al. Correction: Dynamics of clonal hematopoiesis under DNA-damaging treatment in patients with ovarian cancer. Leukemia 38, 1440 (2024). https://doi.org/10.1038/s41375-024-02274-y
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41375-024-02274-y
This article is cited by
-
Dynamics of clonal hematopoiesis and risk of hematologic malignancy
International Journal of Hematology (2024)